康基医疗发布中期业绩 股东应占溢利2.66亿元 同比减少7%

Group 1 - The core viewpoint of the article is that 康基医疗 (Kangji Medical) reported its interim results for the six months ending June 30, 2025, showing a revenue of RMB 497 million, which represents a year-on-year growth of 8.3% [1] - The company's profit attributable to shareholders was RMB 266 million, reflecting a year-on-year decrease of 7% [1] - Earnings per share for the company stood at 22.56 cents [1]